FDA Inspection 1055551 — Bloodworks

Bloodworks — FEI 3001878572

The FDA completed an inspection of Bloodworks on Jun 13, 2018 in Silverdale, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Silverdale, WA (United States)

Citations

IDCFRDescription
1813421 CFR 640.21(g)Informed consent